Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis
- PMID: 22473882
- PMCID: PMC3394902
- DOI: 10.1001/archpediatrics.2011.1669
Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis
Abstract
Objective: To determine whether hospital length of stay(LOS) for acute bronchiolitis is influenced by the infecting pathogen.
Design: A prospective observational cohort study was performed during 3 consecutive years.
Setting: Sixteen US hospitals participated in the study.
Participants: Children younger than 2 years hospitalized with bronchiolitis were included.
Main exposure: The results of nasopharyngeal aspirate polymerase chain reaction pathogen testing served as the main exposure.
Main outcome measure: Hospital LOS was determined.
Results: Of 2207 participants, 72.0% had respiratory syncytial virus (RSV) and 25.6% had human rhinovirus(HRV); the incidence of each of the other viruses and bacteria was 7.8% or less. Multiple pathogen infections were present in 29.8% of the children. There were 1866 children(84.5%) with RSV and/or HRV. Among these 1866 children, the median age was 4 months and 59.5% were male. The median LOS was 2 days (interquartile range,1-4 days). Compared with children who had only RSV,an LOS of 3 or more days was less likely among children with HRV alone (adjusted odds ratio [AOR], 0.36; 95%CI, 0.20-0.63; P.001) and those with HRV plus non-RSV pathogens (AOR, 0.39; 95% CI, 0.23-0.66; P.001)but more likely among children with RSV plus HRV(AOR,1.33; 95% CI, 1.02-1.73; P=.04), controlling for 15 demographic and clinical factors.
Conclusions: In this multicenter study of children hospitalized with bronchiolitis, RSV was the most common virus detected, but HRV was detected in one-quarter of the children. Since 1 in 3 children had multiple virus infections and HRV was associated with LOS, these data challenge the effectiveness of current RSV-based cohorting practices, the sporadic testing for HRV in bronchiolitis research, and current thinking that the infectious etiology of severe bronchiolitis does not affect short-term outcomes.
Conflict of interest statement
All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported
Comment in
-
Bronchiolitis: too-familiar yet too-mysterious disease of childhood.Arch Pediatr Adolesc Med. 2012 Aug;166(8):769-70. doi: 10.1001/archpediatrics.2012.157. Arch Pediatr Adolesc Med. 2012. PMID: 22473888 No abstract available.
Similar articles
-
Viral Codetection and Clinical Outcomes of Infants Hospitalized With Bronchiolitis: A Multicenter Cohort Study.Pediatr Infect Dis J. 2025 Jun 1;44(6):526-531. doi: 10.1097/INF.0000000000004738. Epub 2025 Feb 3. Pediatr Infect Dis J. 2025. PMID: 39898632 Free PMC article.
-
Nirsevimab and Hospitalization for RSV Bronchiolitis.N Engl J Med. 2024 Jul 11;391(2):144-154. doi: 10.1056/NEJMoa2314885. N Engl J Med. 2024. PMID: 38986058
-
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050. Health Technol Assess. 2011. PMID: 21281564 Free PMC article.
-
WITHDRAWN: Glucocorticoids for acute viral bronchiolitis in infants and young children.Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004878. doi: 10.1002/14651858.CD004878.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2010 Oct 06;(10):CD004878. doi: 10.1002/14651858.CD004878.pub3. PMID: 18254063 Updated.
-
Glucocorticoids for acute viral bronchiolitis in infants and young children.Cochrane Database Syst Rev. 2004;(3):CD004878. doi: 10.1002/14651858.CD004878. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004878. doi: 10.1002/14651858.CD004878.pub2. PMID: 15266547 Updated.
Cited by
-
Rhinovirus-induced bronchiolitis: Lack of association between virus genomic load and short-term outcomes.J Allergy Clin Immunol. 2015 Aug;136(2):509-12.e11. doi: 10.1016/j.jaci.2015.02.021. Epub 2015 Mar 31. J Allergy Clin Immunol. 2015. PMID: 25840721 Free PMC article. No abstract available.
-
Use of Cough and Cold Medications in Severe Bronchiolitis before and after a Health Advisory Warning against Their Use.J Pediatr. 2015 Jul;167(1):196-8.e1-2. doi: 10.1016/j.jpeds.2015.03.037. Epub 2015 Apr 15. J Pediatr. 2015. PMID: 25888349 Free PMC article.
-
Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.JAMA Pediatr. 2019 Jun 1;173(6):544-552. doi: 10.1001/jamapediatrics.2019.0384. JAMA Pediatr. 2019. PMID: 30933255 Free PMC article.
-
Virus, allergic sensitisation and cortisol in infant bronchiolitis and risk of early asthma.ERJ Open Res. 2020 Mar 16;6(1):00268-2019. doi: 10.1183/23120541.00268-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32201686 Free PMC article.
-
Predictors of prolonged length of hospital stay for infants with bronchiolitis.J Investig Med. 2018 Aug;66(6):986-991. doi: 10.1136/jim-2018-000708. Epub 2018 Mar 26. J Investig Med. 2018. PMID: 29588331 Free PMC article.
References
-
- Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999 Oct 20;282(15):1440–1446. - PubMed
-
- Miron D, Srugo I, Kra-Oz Z, et al. Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J. 2010 Jan;29(1):e7–e10. - PubMed